netFormulary

Demonstration Formulary

4 Central nervous system

PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control

04-02-02 Antipsychotic depot injections

Aripiprazole Abilify Maintena^®

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Flupentixol Decanoate

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Fluphenazine Decanoate Modecate^®

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Discontinued by UK manufacturer by the end of 2018

Haloperidol Haldol Decanoate^®

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Olanzapine Embonate ZypAdhera^®

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Paliperidone Xeplion^®

Formulary

The APC’s view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Paliperidone Trevicta^®

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Risperidone Risperdal Consta^®

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Zuclopenthixol Decanoate

Formulary

The APC's view is that, on clinical grounds, the status of antipsychotic depot injections should be amber with a framework in place in Primary Care before transfer

HOWEVER, until the commissioning arrangements have been agreed to allow safe transfer of patient care, the status will remain RED

Pipotiazine Palmitate Piportil^® Depot

Non Formulary

Links